Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma-Reference-Cited by-同舟云学术

Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma

Published:2009-01 Issue:3 Volume:20 Page:169-176
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Kannangara Ajith P.,Levitan Denise,Fleischer Alan B.

Publisher

Informa UK Limited

Subject

Dermatology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference13 articles.

1. Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results

2. Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients

3. Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: Results in twenty-nine patients

4. Observations on the use of cancer chemotherapeutic agents in patients with mycosis fungoides

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traitements immunomodulateurs du mycosis fongoïde aux stades précoces;Annales de Dermatologie et de Vénéréologie - FMC;2023-04

2. The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review;International Journal of Molecular Sciences;2022-10-20

3. Benefit/risk Ratio of Low-dose Methotrexate in Cutaneous Lesions of Mycosis Fungoides and Sézary Syndrome;Acta Dermato Venereologica;2021

4. Systemic therapy of cutaneous T-cell lymphoma (CTCL);Chinese Clinical Oncology;2019-02

5. Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome;Current Oncology Reports;2018-03-23